Une nouvelle recherche révèle la dose optimale d’acides gras oméga-3 pour abaisser la tension artérielle

La dose quotidienne optimale d’acides gras oméga-3 pour réduire l’hypertension artérielle semble être d’environ 3 grammes provenant de sources alimentaires ou de suppléments.

Selon une nouvelle étude publiée dans le Journal de l’American Heart Association, environ 3 grammes d’acides gras oméga-3 par jour semblent être la dose optimale pour abaisser la tension artérielle. Ce niveau peut être atteint en consommant des compléments alimentaires ou des aliments.

  • Bien qu’il existe des preuves scientifiques que la consommation d’acides gras oméga-3 dans les aliments ou les compléments alimentaires peut réduire le risque d’hypertension artérielle, la quantité optimale à consommer pour cet avantage n’était pas claire.
  • Un examen de dizaines d’études suggère qu’environ 3 grammes par jour est probablement la quantité optimale d’acides gras oméga-3 à consommer pour abaisser la tension artérielle.
  • Consommer des quantités plus élevées d’acides gras oméga-3 peut être bénéfique pour les personnes à haut risque de développer une maladie cardiovasculaire, bien que des recherches supplémentaires soient nécessaires.
Aliments oméga-3

Les aliments riches en oméga-3 comprennent les poissons gras comme le saumon, le maquereau, les sardines, le thon, le hareng et la truite. Les noix, les graines de lin, le tofu, les graines de chia, le soja et les avocats sont également de bonnes sources alimentaires.

Selon une revue de recherche publiée aujourd’hui (1er juin 2022) dans le Journal de l’American Heart Associationune revue en libre accès à comité de lecture de l’American Heart Association.

Acides gras docosahexaénoïques oméga-3[{” attribute=””>acid (DHA) and eicosapentaenoic acid (EPA) are typically found in fatty fish, such as salmon, sardines, tuna, trout, herring, and oysters. Some people also take combined DHA and EPA in dietary supplements. While some studies suggest that consumption of omega-3 fatty acids may lower blood pressure, the optimal dosage needed to lower blood pressure has not been clear. The National Institutes of Health has established an adequate intake of omega-3 fatty acids for healthy people at 1.1- 1.6 grams daily, depending on age and sex.

Blood Pressure Categories

Blood Pressure Categories Infographic describing the corresponding blood pressure readings between normal and hypertensive crisis. Credit: Copyright American Heart Association

“According to our research, the average adult may have a modest blood pressure reduction from consuming about 3 grams a day of these fatty acids,” said study author Xinzhi Li, M.D., Ph.D., assistant professor and program director of the School of Pharmacy at Macau University of Science and Technology in Macau, China.

Researchers analyzed the results of 71 clinical trials from around the world published from 1987 to 2020. The studies examined the relationship between blood pressure and the omega-3 fatty acids DHA and EPA (either individually or combined) in people aged 18 and older with or without high blood pressure or cholesterol disorders. There were nearly 5,000 participants combined, ranging in age from 22 to 86 years. Participants took dietary and/or prescription supplement sources of fatty acids for an average of 10 weeks.

The analysis found:

  • Compared to adults who did not consume EPA and DHA, those who consumed between 2 and 3 grams daily of combined DHA and EPA omega-3 fatty acids (in supplements, food or both) had reduced systolic (top number) and diastolic (bottom number) blood pressure by an average 2 mm Hg.
  • Consuming more than 3 grams of omega-3 fatty acids daily may have added blood pressure-lowering benefit for adults with high blood pressure or high blood lipids:
  • At 3 grams a day of omega-3s, systolic blood pressure (SBP) decreased an average of 4.5 mm Hg for those with hypertension, and about 2 mm Hg on average for those without.
  • At 5 grams a day of omega-3s, SBP declined an average of nearly 4 mm Hg for those with hypertension and less than 1 mm Hg on average for those without.
  • Similar differences were seen in people with high blood lipids and among those older than age 45. 

About 4-5 ounces of Atlantic salmon provide 3 grams of omega 3 fatty acids. A typical fish oil supplement contains about 300 mg of omega-3s per pill, but doses vary widely.

“Most of the studies reported on fish oil supplements rather than on EPA and DHA omega-3s consumed in food, which suggests supplements may be an alternative for those who cannot eat fatty fish such as salmon regularly,” Li said. “Algae supplements with EPA and DHA fatty acids are also an option for people who do not consume fish or other animal products.”

The U.S. Food and Drug Administration (FDA) announced in June 2019 that it did not object to the use of certain health claims that consuming EPA and DHA omega-3 fatty acids in food or dietary supplements may reduce the risk of hypertension and coronary heart disease. However, they noted that the evidence was inconclusive and highly inconsistent.

“Our study supports the FDA guidance that EPA and DHA omega-3 fatty acids may reduce the risk of coronary heart disease by lowering high blood pressure, especially among people already diagnosed with hypertension,” he said. “However, while our study may add a layer of credible evidence, it does not meet the threshold to make an authorized health claim for omega-3 fatty acids in compliance with FDA regulations.”

Limitations of the review include differences in how blood pressure was measured, and whether the studies examined omega-3 intake from supplements or diet, which may affect the strength of the conclusions.

The American Heart Association recommends eating two servings (3-4 ounces cooked) of fish per week (particularly fatty fish such as salmon) as part of a heart-healthy diet.

Reference: “Omega-3 Polyunsaturated Fatty Acids Intake and Blood Pressure: A Dose-Response Meta-Analysis of Randomized Controlled Trials” 1 June 2022, Journal of the American Heart Association.
DOI: 10.1161/JAHA.121.025071

Co-authors are Xin Zhang, Ph.D.; Jennifer A. Ritonja, Ph.D.; Na Zhou, Ph.D.; and Bingshu E. Chen, Ph.D. Authors’ disclosures are listed in the manuscript.

The study was funded by the Macau Science and Technology Development Fund and Faculty Research Grants of Macau University of Science and Technology.

Add Comment